Diagnostic Accuracy of Endocervical Curettage in Detecting CIN2+ with Non-Visible Squamocolumnar Junction
DOI:
https://doi.org/10.63682/jns.v14i17S.5691Keywords:
Endocervical Curettage, CIN2 , Colposcopy, Squamocolumnar Junction, Diagnostic Accuracy, Cervical CancerAbstract
Background: Cervical cancer remains a significant health burden, particularly in low-resource settings. Accurate detection of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) is critical for prevention. Colposcopy-directed biopsy (CDB) may miss lesions when the squamocolumnar junction (SCJ) is not visible, especially in women with Type 3 transformation zone (TZ). Endocervical curettage (ECC) has been proposed as a complementary diagnostic tool, though its utility remains underexplored. This study evaluates the diagnostic accuracy of ECC in detecting CIN2+ lesions, particularly in women with non-visible squamous cell junctional lesions (SCJ).
Methods: This cross-sectional study was conducted at the Colposcopy Clinic of the Gynaecological Oncology Department, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh, from November 2021 to October 2022. A total of 117 women aged 30–60 years with abnormal cervical screening results underwent colposcopy, CDB, and ECC. SCJ visibility was recorded. Histopathological findings from CDB and ECC were analyzed to assess ECC's diagnostic performance. Statistical analysis included chi-square tests and logistic regression.
Results: CIN2+ was detected in 35.9% of women using either colposcopy-directed biopsy (CDB) or endocervical curettage (ECC), with both methods identifying exclusive cases. Non-visible squamocolumnar junction (SCJ) significantly increased ECC-detected CIN2+ (p=0.021). Multivariate analysis confirmed SCJ non-visibility as an independent predictor (AOR=2.67, p=0.041), while age ≥50 lost significance. CDB and ECC are complementary in CIN2+ detection.
Conclusion: ECC enhances CIN2+ detection in women with non-visible SCJ and should be considered in cases of unsatisfactory colposcopy to improve diagnostic yield.
Downloads
Metrics
References
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. The lancet global health. 2023 Feb 1;11(2):e197-206.
Uddin AK, Sumon MA, Pervin S, Sharmin F. Cervical cancer in Bangladesh. South Asian Journal of Cancer. 2023 Jan;12(01):036-8.
World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization; 2021 Jul 6.
Pimple S, Mishra G. Cancer cervix: Epidemiology and disease burden. Cytojournal. 2022 Mar 29; 19:21.
Hariprasad R, Mittal S, Basu P. Role of colposcopy in the management of women with abnormal cytology. Cytojournal. 2022 Jun 14; 19:40.
Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M, Perrotta M, Prendiville W, Russell P, Sideri M, Strander B. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstetrics & Gynecology. 2012 Jul 1;120(1):166-72.
Husaiyin S, Han L, Wang L, Ma C, Ainiwaer Z, Rouzi N, Akemujiang M, Simayil H, Aniwa Z, Nurimanguli R, Niyazi M. Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged> 30 years in Xinjiang. BMC cancer. 2018 Dec; 18:1-9.
Gage JC, Duggan MA, Nation JG, Gao S, Castle PE. Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations. American journal of obstetrics and gynecology. 2010 Nov 1;203(5):481-e1.
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. American journal of clinical pathology. 2012 Apr 1;137(4):516-42.
Driggers RW, Zahn CM. To ECC or not to ECC: the question remains. Obstetrics and gynecology clinics of North America. 2008 Dec 1;35(4):583-97.
Hu SY, Zhang WH, Li SM, Li N, Huang MN, Pan QJ, Zhang X, Han Y, Zhao FH, Chen W, Qiao YL. Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy. Medicine. 2017 Apr 1;96(17): e6689.
Liu AH, Walker J, Gage JC, Gold MA, Zuna R, Dunn ST, Schiffman M, Wentzensen N. Diagnosis of cervical precancers by endocervical curettage at colposcopy of women with abnormal cervical cytology. Obstetrics & Gynecology. 2017 Dec 1;130(6):1218-25.
Van Der Marel J, Rodriguez A, Del Pino M, van Baars R, Jenkins D, van de Sandt MM, Torné A, Ordi J, ter Harmsel B, Verheijen RH, Schiffman M. The value of endocervical curettage in addition to biopsies in women referred to colposcopy. Journal of lower genital tract disease. 2015 Oct 1;19(4):282-7.
Wei B, Li Q, Seery S, Qiao Y, Jiang Y. Endocervical curettage for diagnosing high-grade squamous intraepithelial lesions or worse in women with type 3 transformation zone lesions: a retrospective, observational study. BMC Women's Health. 2023 May 9;23(1):245.
Xue P, Wei B, Seery S, Li Q, Ye Z, Jiang Y, Qiao Y. Development and validation of a predictive model for endocervical curettage in patients referred for colposcopy: a multicenter retrospective diagnostic study in China. Chinese Journal of Cancer Research. 2022 Aug 30;34(4):395.
Guo M, Xu J, Du J. Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis. BMC public health. 2021 Dec; 21:1-4.
Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination—review of current perspectives. Journal of oncology. 2019;2019(1):3257939.
Imannezhad S, Sabzevari A, Rahdari A, Akhondi M. Diagnostic value of performing endocervical curettage at the time of colposcopy procedure; a systematic review. Reviews in Clinical Medicine. 2016 Apr 1;3(2).
Akladios C, Lecointre L, Baulon E, Thoma V, Averous G, Fender M, Lefebvre F, Baldauf JJ. Reliability of endocervical curettage in the diagnosis of high-grade cervical neoplasia and cervical cancer in selected patients. Anticancer Research. 2015 Jul 1;35(7):4183-9.
World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of mRNA tests for human papillomavirus (HPV). World Health Organization; 2021 Dec 17.
Agustiansyah P, Sanif R, Nurmaini S. Epidemiology and risk factors for cervical cancer. Bioscientia Medicina: Journal of Biomedicine and Translational Research. 2021 Apr 5;5(7):624-31
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
